Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F Smit

Showing results (121-130 of 185) with videos related to

Pageof 19
Sort By:
Lung Cancer (Amsterdam, Netherlands)|October 2, 2021
The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancerP J M Joosten, A J de Langen, V van der Noort, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1995
Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinomaJ G Kosterink, M W de Jonge, E F Smit, et al.
Anticancer Research|September 3, 1999
99mTc-Sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumoursM Bakker, W T van der Graaf, D A Piers, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2015
Costs of non-small cell lung cancer in the NetherlandsN van der Linden, M L Bongers, V M H Coupé, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1994
Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assayS Withoff, E F Smit, G J Meersma, et al.
ESMO Open|August 13, 2022
Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studiesC A Powell, S Modi, H Iwata, et al.
Journal of Clinical Pathology|May 3, 2002
Multidrug resistance related molecules in human and murine lungG L Scheffer, A C L M Pijnenborg, E F Smit, et al.
The European Respiratory Journal|January 25, 2008
Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertensionM J Overbeek, J-W Lankhaar, N Westerhof, et al.
The European Respiratory Journal|March 14, 2009
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathyM J Overbeek, M C Vonk, A Boonstra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 14, 2006
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975F Efficace, A Bottomley, E F Smit, et al.
Pageof 19

Showing results (121-130 of 185) with videos related to

Sort By:
Pageof 19
Lung Cancer (Amsterdam, Netherlands)|October 2, 2021
The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancerP J M Joosten, A J de Langen, V van der Noort, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1995
Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinomaJ G Kosterink, M W de Jonge, E F Smit, et al.
Anticancer Research|September 3, 1999
99mTc-Sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumoursM Bakker, W T van der Graaf, D A Piers, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2015
Costs of non-small cell lung cancer in the NetherlandsN van der Linden, M L Bongers, V M H Coupé, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 1, 1994
Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assayS Withoff, E F Smit, G J Meersma, et al.
ESMO Open|August 13, 2022
Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studiesC A Powell, S Modi, H Iwata, et al.
Journal of Clinical Pathology|May 3, 2002
Multidrug resistance related molecules in human and murine lungG L Scheffer, A C L M Pijnenborg, E F Smit, et al.
The European Respiratory Journal|January 25, 2008
Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertensionM J Overbeek, J-W Lankhaar, N Westerhof, et al.
The European Respiratory Journal|March 14, 2009
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathyM J Overbeek, M C Vonk, A Boonstra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 14, 2006
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975F Efficace, A Bottomley, E F Smit, et al.
Pageof 19